Status: open
Allergan (Restasis)
Defendant: Allergan
Residents of certain states who bought and paid the purchase price of Restasis between May 1, 2015 and July 31, 2021 may be eligible for cash payment. The companies reached a settlement over allegations of delaying the less expensive generic version of Restasis and anticompetitive behavior.